Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jan 17 04:00PM ET
62.25
Dollar change
-0.62
Percentage change
-0.99
%
IndexS&P 500 P/E10.80 EPS (ttm)5.77 Insider Own1.09% Shs Outstand510.08M Perf Week0.68%
Market Cap31.43B Forward P/E8.62 EPS next Y7.23 Insider Trans1.01% Shs Float499.34M Perf Month5.21%
Income3.07B PEG1.01 EPS next Q0.49 Inst Own98.47% Short Float1.61% Perf Quarter-10.17%
Sales161.73B P/S0.19 EPS this Y2.23% Inst Trans-5.60% Short Ratio1.27 Perf Half Y-5.24%
Book/sh53.53 P/B1.16 EPS next Y5.81% ROA3.68% Short Interest8.04M Perf Year-20.19%
Cash/sh- P/C- EPS next 5Y10.68% ROE11.66% 52W Range55.03 - 81.42 Perf YTD2.76%
Dividend Est.- P/FCF128.28 EPS past 5Y17.00% ROI6.85% 52W High-23.54% Beta0.45
Dividend TTM- Quick Ratio- Sales past 5Y20.88% Gross Margin- 52W Low13.12% ATR (14)1.72
Dividend Ex-Date- Current Ratio1.10 EPS Y/Y TTM29.54% Oper. Margin1.88% RSI (14)54.43 Volatility2.36% 2.65%
Employees76000 Debt/Eq0.64 Sales Y/Y TTM7.75% Profit Margin1.90% Recom2.00 Target Price78.16
Option/ShortYes / Yes LT Debt/Eq0.64 EPS Q/Q57.17% Payout0.00% Rel Volume0.69 Prev Close62.87
Sales Surprise10.79% EPS Surprise19.58% Sales Q/Q10.46% EarningsFeb 04 BMO Avg Volume6.34M Price62.25
SMA201.22% SMA503.34% SMA200-9.80% Trades Volume4,387,651 Change-0.99%
Date Action Analyst Rating Change Price Target Change
Dec-17-24Resumed JP Morgan Overweight $80 → $75
Dec-13-24Upgrade UBS Neutral → Buy $79 → $80
Dec-10-24Downgrade Jefferies Hold → Underperform $68 → $52
Jul-24-24Downgrade Jefferies Buy → Hold $83 → $69
May-30-24Initiated Robert W. Baird Neutral $83
Mar-21-24Downgrade Stephens Overweight → Equal-Weight $92 → $85
Mar-06-24Initiated Barclays Overweight $101
Jan-02-24Upgrade Wells Fargo Equal Weight → Overweight $82 → $90
Sep-05-23Upgrade BofA Securities Underperform → Neutral $79 → $72
Aug-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $94 → $73
Jan-15-25 09:37AM
09:00AM
Jan-14-25 12:00PM
07:41AM
Jan-13-25 10:43AM
09:00AM Loading…
Jan-09-25 09:00AM
06:34AM
Jan-08-25 01:35PM
Jan-07-25 09:00AM
Dec-28-24 05:04PM
Dec-18-24 07:54PM
04:57PM
Dec-16-24 07:00AM
Dec-13-24 05:38AM
Dec-12-24 04:11PM
03:33PM Loading…
03:33PM
12:41PM
06:00AM
05:30AM
Dec-10-24 09:36PM
10:22AM
Dec-06-24 03:47AM
Dec-05-24 09:57PM
07:01PM
Dec-04-24 09:00AM
04:00AM
Dec-03-24 09:00AM
Dec-02-24 02:45PM
Nov-27-24 03:19PM
Nov-26-24 07:27AM
05:00AM Loading…
05:00AM
05:00AM
Nov-21-24 08:33AM
Nov-20-24 12:10PM
Nov-19-24 06:15AM
Nov-15-24 10:45AM
Nov-14-24 05:57AM
Nov-13-24 05:49AM
Nov-07-24 07:00AM
Nov-06-24 11:17AM
09:43AM
Nov-04-24 01:16PM
Nov-01-24 05:51PM
Oct-30-24 06:14PM
08:30AM
Oct-29-24 11:05AM
11:00AM
07:00AM
Oct-28-24 05:13PM
05:07PM
Oct-26-24 06:25AM
03:05AM
01:06AM
12:38AM
Oct-25-24 04:02PM
01:30PM
12:55PM
11:47AM
11:12AM
10:26AM
10:21AM
09:46AM
09:30AM
08:04AM
07:29AM
07:10AM
06:15AM
06:09AM
06:00AM
Oct-24-24 02:24PM
Oct-23-24 04:32AM
Oct-22-24 09:15AM
Oct-21-24 06:58PM
Oct-19-24 07:00AM
Oct-18-24 10:00AM
Oct-17-24 05:10PM
03:04PM
08:00AM
Oct-15-24 10:07AM
07:00AM
Oct-14-24 02:56PM
Oct-12-24 07:41AM
Oct-11-24 05:30AM
Oct-09-24 06:29AM
Oct-08-24 08:30AM
Oct-07-24 08:00AM
Oct-02-24 08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Greco ThomasDirectorDec 18 '24Buy59.7517,0001,015,75019,309Dec 19 05:39 PM
Dallas H JamesDirectorDec 16 '24Buy59.011,69399,9041,693Dec 17 07:34 PM
BLUME JESSICA L.DirectorDec 16 '24Buy59.4825014,870250Dec 17 07:33 PM
COUGHLIN CHRISTOPHER JDirectorDec 16 '24Buy59.4410,000594,40036,358Dec 17 07:33 PM
Samuels Theodore R. IIDirectorDec 13 '24Buy58.865,000294,30023,000Dec 17 07:33 PM
Asher Andrew LynnChief Financial OfficerNov 13 '24Buy58.1417,2001,000,008486,847Nov 13 06:07 PM
LONDON SARAHChief Executive OfficerNov 08 '24Buy60.804,117250,314667,229Nov 08 06:15 PM
COUGHLIN CHRISTOPHER JDirectorMay 14 '24Sale76.7587867,3820May 24 05:28 PM
FASOLA KENNETH JPresidentMay 13 '24Sale77.628,000620,960300,357May 15 06:10 PM
Robinson Lori JeanDirectorFeb 13 '24Option Exercise54.6510,000546,50021,455Feb 15 06:31 PM
Robinson Lori JeanDirectorFeb 13 '24Sale77.4110,000774,10011,455Feb 15 06:31 PM
FASOLA KENNETH JPresidentFeb 07 '24Sale75.0712,000900,817235,365Feb 08 07:38 PM
BMY Bristol-Myers Squibb Co daily Stock Chart
IndexS&P 500 P/E- EPS (ttm)-3.60 Insider Own0.08% Shs Outstand2.03B Perf Week0.82%
Market Cap114.17B Forward P/E8.06 EPS next Y6.98 Insider Trans0.07% Shs Float2.03B Perf Month0.75%
Income-7258.00M PEG- EPS next Q1.47 Inst Own77.71% Short Float1.23% Perf Quarter5.47%
Sales47.44B P/S2.41 EPS this Y-87.99% Inst Trans0.25% Short Ratio2.36 Perf Half Y32.79%
Book/sh8.45 P/B6.66 EPS next Y674.08% ROA-7.85% Short Interest24.93M Perf Year12.63%
Cash/sh3.99 P/C14.10 EPS next 5Y-5.00% ROE-31.46% 52W Range39.35 - 61.08 Perf YTD-0.48%
Dividend Est.2.39 (4.25%) P/FCF8.27 EPS past 5Y5.14% ROI-10.78% 52W High-7.84% Beta0.45
Dividend TTM2.42 (4.30%) Quick Ratio1.09 Sales past 5Y17.18% Gross Margin55.87% 52W Low43.05% ATR (14)1.11
Dividend Ex-DateJan 03, 2025 Current Ratio1.24 EPS Y/Y TTM-190.62% Oper. Margin17.62% RSI (14)47.19 Volatility1.80% 1.86%
Employees34100 Debt/Eq3.00 Sales Y/Y TTM5.56% Profit Margin-15.30% Recom2.57 Target Price60.37
Option/ShortYes / Yes LT Debt/Eq2.93 EPS Q/Q-36.16% Payout59.82% Rel Volume1.03 Prev Close56.38
Sales Surprise5.57% EPS Surprise20.47% Sales Q/Q8.44% EarningsFeb 06 BMO Avg Volume10.58M Price56.29
SMA20-0.69% SMA50-1.80% SMA20013.59% Trades Volume10,908,444 Change-0.16%
Date Action Analyst Rating Change Price Target Change
Dec-16-24Upgrade Jefferies Hold → Buy $70
Dec-10-24Resumed BofA Securities Neutral $63
Nov-15-24Initiated Wolfe Research Peer Perform
Nov-13-24Upgrade Daiwa Securities Neutral → Outperform
Nov-12-24Upgrade Leerink Partners Market Perform → Outperform $73
Oct-25-24Downgrade Citigroup Buy → Neutral $75 → $55
Oct-17-24Initiated Bernstein Mkt Perform $56
Jul-29-24Downgrade Barclays Overweight → Equal Weight $41
Mar-11-24Downgrade Societe Generale Buy → Hold
Feb-06-24Downgrade Redburn Atlantic Buy → Neutral $77 → $54
Jan-17-25 11:10AM
09:46AM
Jan-13-25 03:13PM
07:00AM
Jan-10-25 12:50PM
08:30AM Loading…
08:30AM
Jan-06-25 09:00AM
Jan-03-25 06:59AM
Dec-31-24 01:14PM
Dec-30-24 02:14PM
Dec-27-24 05:37PM
Dec-23-24 06:59AM
06:45AM
Dec-19-24 02:28PM
06:59AM
01:48AM Loading…
01:48AM
Dec-18-24 09:00AM
08:45AM
Dec-17-24 06:30AM
Dec-11-24 04:17PM
Dec-09-24 05:45PM
Dec-07-24 05:30AM
Dec-03-24 08:00AM
Dec-02-24 07:44AM
Nov-26-24 06:59AM
Nov-22-24 04:09PM
11:30AM
Nov-19-24 06:59AM
Nov-18-24 07:30AM
12:41AM
07:22PM Loading…
Nov-15-24 07:22PM
08:23AM
06:59AM
Nov-13-24 04:07PM
Nov-12-24 04:05PM
07:00AM
Nov-11-24 07:00PM
04:32PM
04:04PM
03:45PM
10:12AM
09:39AM
06:59AM
Nov-08-24 09:34AM
Nov-05-24 05:00PM
Nov-01-24 03:07PM
Oct-31-24 04:16PM
04:12PM
02:43PM
10:03AM
07:12AM
06:59AM
Oct-29-24 11:17AM
Oct-28-24 06:59AM
Oct-26-24 07:00AM
Oct-16-24 04:21PM
Oct-15-24 06:09PM
Oct-14-24 09:59PM
Oct-07-24 05:30AM
Oct-03-24 05:35PM
01:11PM
Sep-30-24 07:00AM
Sep-27-24 07:38PM
04:18PM
02:17PM
11:58AM
11:06AM
11:00AM
09:44AM
09:36AM
06:59AM
05:59AM
Sep-26-24 09:05PM
07:20PM
Sep-25-24 08:29PM
Sep-18-24 06:59AM
Sep-16-24 05:25AM
Sep-15-24 08:55AM
Sep-12-24 06:59AM
Sep-10-24 05:45PM
Sep-09-24 06:59AM
Sep-08-24 02:30AM
Sep-06-24 07:00AM
Sep-01-24 03:33AM
Aug-28-24 06:19PM
Aug-27-24 06:59AM
Aug-26-24 06:59AM
Aug-21-24 06:59AM
Aug-19-24 06:59AM
Aug-16-24 07:30AM
Aug-15-24 05:30PM
03:48PM
12:34PM
10:49AM
07:49AM
Aug-08-24 06:30AM
Jul-29-24 06:30AM
Jul-27-24 11:31AM
Jul-26-24 07:06PM
01:26PM
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holzer Phil MSVP and ControllerNov 04 '24Sale55.6270038,93011,760Nov 05 05:53 PM
BOERNER CHRISTOPHER S.Chief Executive OfficerNov 01 '24Option Exercise0.002,9640104,169Nov 05 05:42 PM
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Nov 01 '24Buy54.671,830100,05562,109Nov 05 05:41 PM
Holzer Phil MOfficerNov 04 '24Proposed Sale55.6270038,930Nov 04 11:20 AM
Gallman CariEVP, Corporate AffairsOct 02 '24Option Exercise0.004,55806,667Oct 03 06:33 PM
Gallman CariEVP, Corporate AffairsAug 01 '24Option Exercise0.001,06102,493Aug 05 06:01 PM
Shanahan KarinEVP, Glob. Prod. Dev. & SupplyApr 01 '24Option Exercise0.003,30606,532Apr 02 06:45 PM
Lenkowsky AdamEVP, Chief Commercial OfficerMar 10 '24Option Exercise0.0015,016013,859Mar 12 09:54 PM
LEUNG SANDRAEVP, General CounselMar 10 '24Option Exercise0.0046,7840371,312Mar 12 09:43 PM
Plenge Robert MEVP, Chief Research OfficerMar 10 '24Option Exercise0.009,143015,182Mar 12 09:21 PM
Poole Ahn AmandaEVP, Chief Human ResourcesMar 10 '24Option Exercise0.005,45804,841Mar 12 09:11 PM
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Mar 10 '24Option Exercise0.0038,388080,256Mar 12 08:40 PM
Holzer Phil MSVP and ControllerMar 10 '24Option Exercise0.005,520014,916Mar 12 08:31 PM
Hoch LynellePresident, Cell Therapy Org.Mar 10 '24Option Exercise0.004,35103,781Mar 12 08:01 PM
Gallman CariEVP, Corporate AffairsMar 10 '24Option Exercise0.002,76102,655Mar 12 08:00 PM
BOERNER CHRISTOPHER S.Chief Executive OfficerMar 10 '24Option Exercise0.0054,6380129,769Mar 12 07:58 PM
Elkins David VEVP, Chief Financial OfficerMar 10 '24Option Exercise0.0064,3260225,111Mar 12 05:43 PM
Caforio GiovanniExecutive Chair of the BoardMar 10 '24Option Exercise0.00190,1300529,662Mar 12 05:42 PM
Meyers Gregory ScottEVP, Chief Digital & Tech Off.Feb 01 '24Option Exercise0.002,54306,040Feb 05 07:10 PM